Kasim Kutay
CEO · Novo Holdings
Kasim Kutay, CEO of Novo Holdings, leads a world-leading life sciences investor that deploys capital across all development stages—from seeds to principal investments—primarily in biotech, pharma, and bioindustrial sectors, with a distinctive thesis centered on planetary health and green technology including decarbonization[2][3][5]. The firm’s venture unit deployed $530 million in 2023, adding 1…
- Stages: Early Stage Venture, Late Stage Venture, Post-Ipo, Private Equity, Seed
- Focus: Finance, Financial Services, FinTech, Venture Capital, Biotechnology, Health Care, Pharmaceutical, Medical, Therapeutics, Biopharma, Mdeical Device, Life Science, Health Diognostics, Clinical Trials, Early Stage Venture, Late Stage Venture, Post-Ipo, Private Equity, Seed
- Location: Hellerup, Hovedstaden, Denmark
Website
Browse all investors · Browse founders
